Association between ataxia telangiectasia mutated gene polymorphisms and breast cancer in taiwanese females

Anticancer Research

Volumn 30, Issue 12, 2010, Pages 5217-5222

  Wang, Hwei Chung ^a   Chang, Wen Shin ^a   Tsai, R U Yin ^a   Tsai, Chia Wen ^a,b   Liu, Liang Chih ^a   Su, Chen Hsien ^a   Cheng, Hui N I ^a   Tsou, Yung A N ^a   Sun, Shung Shung ^a   Lin, Cheng Chieh ^a   Bau, D A Tian ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

ATM; Breast cancer; Carcinogenesis; Polymorphism

Indexed keywords

ADULT; ALLELE; ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; TAIWAN; TUMOR SUPPRESSOR PROTEINS;

EID: 78751543535     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Meindl A: Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 97: 472-480, 2002.
2. Ripperger T, Gadzicki D, Meindl A and Schlegelberger B: Breast cancer susceptibility: current knowledge and implications for genetic counselling. Eur J Hum Genet 17: 722-731, 2009.
3. Robson M and Offit K: Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med 357: 154-162, 2007.
4. Turnbull C and Rahman N: Genetic predisposition to breast cancer: past, present, and future. Annu Rev Genomics Hum Genet 9: 321-345, 2008.
5. Swift M, Reitnauer PJ, Morrell D and Chase CL: Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316: 1289-1294,1987.
6. Chen J, Birkholtz GG, Lindblom P, Rubio C and Lindblom A: The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res 55: 1376-1379, 1998.
7. Borresen AL, Andersen TI, Tretli S, Heiberg A and Moller P: Breast cancer and other cancers in Norwegian families with ataxiatelangiectasia. Genes Chromosomes Cancer 2: 339-340, 1990.
8. Abraham RT: PI 3-kinase related kinases: 'big' players in stressinduced signaling pathways. DNA Repair (Amst) 5: 883-887, 2004.
9. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS and Shiloh Y: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 265: 1749-1753, 1995.
10. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y and Ziv Y: Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281: 1674-1677, 1998.
11. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan;tan MB and Siliciano JD: Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677-1679, 1998.
12. Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O, Moas M, Buschmann T, Ronai Z, Shiloh Y, Kastan MB, Katzir E and Oren M: ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev 15: 1067-1077, 2001.
13. Bartek J, Falck J and Lukas J: CHK2 kinase - a busy messenger. Nat Rev Mol Cell Biol 2: 877-886, 2001.
14. Timme TL, Goltsov A, Tahir S, Li L, Wang J, Ren C, Johnston RN and Thompson TC: Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis. Oncogene 19: 3256-3265, 2000.
15. Lim DS, Kim ST, Xu B, Maser RS, Lin J, Petrini JH and Kastan MB: ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404: 613-617, 2000.
16. Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D, Easton DF, Stratton MR and Rahman N: ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 55: 873-875, 2006.
17. Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, Byrd P, Taylor M and Easton DF: Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 97: 813-822, 2005.
18. Barrett JC, Fry B, Mailer J and Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265, 2005.
19. Bau DT, Tseng HC, Wang CH, Chiu CF, Hua CH, Wu CN, Liang SY, Wang CL, Tsai CW and Tsai MH: Oral cancer and genetic polymorphism of DNA double-strand break gene Ku70 in Taiwan. Oral Oncol 44: 1047-1051, 2008.
20. Chang CH, Wang RF, Tsai RY, Wu HC, Wang CH, Tsai CW, Chang CL, Tsou YA, Liu CS and Bau DT: Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. Anticancer Res 29: 3903-3907, 2009.
21. Chiu CF, Tsai MH, Tseng HC, Wang CL, Tsai FJ, Lin CC and Bau DT: A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 44: 582-586, 2008.
22. Chiu CF, Tsai MH, Tseng HC, Wang CL, Wang CH, Wu CN, Lin CC and Bau DT: A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 44: 898-902, 2008.
23. Chiu CF, Wang CH, Wang CL, Lin CC, Hsu NY, Weng JR and Bau DT: A novel single nucleotide polymorphism in XRCC4 gene is associated with gastric cancer susceptibility in Taiwan. Ann Surg Oncol 15: 514-518, 2008.
24. Chiu CF, Wang HC, Wang CH, Wang CL, Lin CC, Shen CY, Chiang SY and Bau DT: A new single nucleotide polymorphism in XRCC4 gene is associated with breast cancer susceptibility in Taiwanese patients. Anticancer Res 25: 267-270, 2008.
25. Hsu CF, Tseng HC, Chiu CF, Liang SY, Tsai CW, Tsai MH and Bau DT: Association between DNA double-strand break gene Ku80 polymorphisms and oral cancer susceptibility. Oral Oncol 45:789-793, 2009.
26. Tsai MH, Tseng HC, Liu CS, Chang CL, Tsai CW, Tsou YA, Wang RF, Lin CC, Wang HC, Chiu CF and Bau DT: Interaction of EXO1 genotypes and smoking habit in oral cancer in Taiwan. Oral Oncol 45: e90-94, 2009.
27. Wang HC, Chiu CF, Tsai RY, Kuo YS, Chen HS, Wang RF, Tsai CW, Chang CH, Lin CC and Bau DT: Association of genetic polymorphisms of EXOl gene with risk of breast cancer in Taiwan. Anticancer Res 29: 3897-3901, 2009.
28. Wang HC, Liu CS, Chiu CF, Chiang SY, Wang CH, Wang RF, Lin CC, Tsai RY and Bau DT: Significant association of DNA repair gene Ku80 genotypes with breast cancer susceptibility in Taiwan. Anticancer Res 29: 5251-5254, 2009.
29. Dombernowsky SL, Weischer M, Allin KH, Bojesen SE, Tybjaerg-Hansen A and Nordestgaard BG: Risk of cancer by ATM missense mutations in the general population. J Clin Oncol 26:3057-3062, 2008.
30. Shiloh Y and Kastan MB: ATM: Genome stability, neuronal development, and cancer cross paths. Adv Cancer Res 55: 209-254, 2001.
31. Angele S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gerard JP and Hall J: ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 63: 8717-8725, 2003.
32. Lee K.-M. Choi J.-Y. Sue K.P. Chung H.-W. Ahn B. Yoo K.-Y. Han W. Noh D.-Y. Ahn S.-H. Kim H. Wei Q. Kang D. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk Cancer Epidemiology Biomarkers and Prevention 2005 14 4 821-825 DOI 10.1158/1055-9965.EPI-04-0330 32 Lee KM, Choi JY, Park SK, Chung HW, Ahn B, Yoo KY, Han W, Noh DY, Ahn SH, Kim H, Wei Q and Kang D: Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14: 821-825, 2005. (Pubitemid 40478542)
33. Athma P, Rappaport R and Swift M: Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92: 130-134, 1996.
34. Broeks A, Urbanus JH, Floore AN, Dahler EC, Klijn JG, Rutgers EJ, Devilee P, Russell NS, van Leeuwen FE and van't Veer LJ: ATM heterozygous germline mutations contribute to breast cancer susceptibility. Am J Hum Genet 66: 494-500, 2000.